Reported Feb 1, 2017 · Terminated

Mallinckrodt Pharmaceuticals INOmax DSIR Plus delivery system. Model 10007. Delivers INOMAX (nitric oxide for…

INO Therapeutics (dba Ikaria)

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: INO Therapeutics (dba Ikaria) · 6603 Femrite Dr · Madison, WI · 53718-6801

Is this the product you have?

  • Mallinckrodt Pharmaceuticals INOmax DSIR Plus delivery system. Model 10007. Delivers INOMAX (nitric oxide for inhalation). The INOmax DSIR uses a dual-channel design to ensure the safe delivery of INOMAX. The first channel has the delivery CPU, the flow controller and the injector module to ensure the accurate delivery of NO. The second channel is the monitoring system, which includes a separate monitor CPU, the gas cells (NO, NO2, and 02 cells) and the user interface including the display and alarms. The dual-channel approach to delivery and monitoring permits INOMAX delivery independent of monitoring but also allows the monitoring system to shutdown INOMAX delivery if it detects a fault in the delivery system such that the NO concentration could become greater than 100 ppm. The delivery system can also shut down delivery if it detects certain serious problems with the monitoring system.
Lot codes and dates
  • Serial Numbers
    • DS20070030
    • DS20070043
    • DS20070094
    • DS20070268
    • DS20090096
    • DS20090458
    • DS20090484
    • DS20090539
    • DS20090620
    • DS20090645
    • DS20100071
    • DS20100118
    • DS20100216
    • DS20100266
    • DS20100268
    • DS20100330
    • DS20100439
    • DS20100496
    • DS20100604
    • DS20100675
    • DS20100744
    • DS20100762
    • DS20100950
    • DS20101199
    • DS20101337
    • DS20101359
    • DS20101369
    • DS20101406
    • DS20101443
    • DS20101524
    • DS20110242
    • DS20110480
    • DS20110577
    • DS20110849
    • DS20110868
    • DS20110912
    • DS20110915
    • DS20110972
    • DS20110976
    • DS20110990
    • DS20120008
    • DS20120161
    • DS20120266
    • DS20120281
    • DS20120370
Amount recalled
45

Where it was sold

Why it was recalled

Mallinckrodt discovered that some devices may have been manufactured with an out-of-tolerance manometer which can result in in an inaccurate proportional valve calibration table in an affected device.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new INO Therapeutics (dba Ikaria) recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA device enforcement) notice

Notice updated Dec 20, 2017 · Data as of Sep 19, 5:22 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.